Open Access10.1002/ANBR.202100109
Lipid Nanoparticles for Drug Delivery
Letao Xu,Xing Wang,Yun Liu,Guangze Yang,Robert J. Falconer,Chun-Xia Zhao,Chun-Xia Zhao +6 more
- 25 Nov 2021
- pp 2100109
258
About: The article was published on 25 Nov 2021. and is currently open access. The article focuses on the topics: Solid lipid nanoparticle & Drug delivery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment.
Patihul Husni,Chaemin Lim +1 more
TL;DR: In this article , the key elements of these types of LDCs in cancer treatment are outlined and discussed in detail on the concepts and benefits of LCLs, the various types of tumor microenvironment stimuli-responsive LDC (such as pH, redox, enzyme, or reactive oxygen species-responsive) and the current status of LDLs in clinical trials.
Additional file 1 of Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier
Fricker Gert
- 18 Sep 2024
Abstract: Supplementary Material 1
Liposomes for epilepsy treatment: Toward better brain targeting and reduced toxicity
Zainab Lafi,Nisreen Asha +1 more
References
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh,Christopher C. Venters,Chao Di,Anna Maria Pinto,Lili Wan,Ihab Younis,Zhiqiang Cai,Chie Arai,Byung Ran So,Jingqi Duan,Gideon Dreyfuss +10 more
TL;DR: An unexpected role for U1 homeostasis (available U1 relative to transcription) in oncogenic and activated cell states is revealed, and U1 is suggested as a potential target for their modulation.
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more
TL;DR: An updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs and selective diagnosis through disease marker molecules is presented.
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
TL;DR: Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.
Doxil®--the first FDA-approved nano-drug: lessons learned.
TL;DR: This review summarizes historical and scientific perspectives of Doxil development and lessons learned from its development and 20 years of its use and demonstrates the obligatory need for applying an understanding of the cross talk between physicochemical, nano-technological, and biological principles.
3.9K
Nanocapsule formation by interfacial polymer deposition following solvent displacement
TL;DR: In this paper, an attempt was made to elucidate the mechanisms of formation in terms of interfacial turbulence between two unequilibrated liquid phases involving flow, diffusion and surface tension decrease (Marangoni effect).
2.2K